Navigation Links
CryoLife Announces Record Preservation Services and Product Revenues for 2007
Date:1/10/2008

s release that look forward in time or that express management's beliefs, expectations or hopes are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include those regarding anticipated revenues for the fourth quarter and full year of 2007. These future events may not occur as and when expected, if at all, and, together with the Company's business, are subject to various risks and uncertainties. These risks and uncertainties include that completion by the Company's management and independent auditors of customary quarter-end closing procedures could result in an adjustment to the Company's fourth quarter and full year 2007 revenue numbers, and other risk factors detailed in CryoLife's Securities and Exchange Commission filings, including CryoLife's Form 10-K filing for the year ended December 31, 2006, its most recent Form 10-Q, and the Company's other SEC filings. The Company does not undertake to update its forward- looking statements.

CRYOLIFE, INC.

Financial Highlights

(In thousands)

Three Months Ended Twelve Months Ended

December 31, December 31,

2007 2006 2007 2006

(Unaudited) (Unaudited)

Revenues from:

Cardiovascular $6,511 $4,438 $22,098 $15,988

Vascular 5,920 3,890 22,702 16,956

Orthopaedic 552 1,911 4,202 7,134

Total preservation

services 12,983 10,239 49,002 40,078

BioGlue 11,511 10,491 43,884 40,025

Other implantable

medical devices 105
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. CryoLife Names Philip Theodore as Vice President, General Counsel
2. CryoLife to Present at Bear Stearns Healthcare and First Albany Capitals Regenerative Technologies Conferences in New York
3. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
4. CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million
5. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
6. CryoLife to Present at 19th Annual Piper Jaffray Health Care Conference in New York
7. CryoLife to Present at OneMedPlace Finance Forum
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... DUBLIN , Oct. 22, 2014 ... "Organic Electronics Market by Material, by Application, Geography ... report to their offering. Organic electronics, ... a branch of material science which deals with small ... as organic because small molecules and polymers are carbon ...
(Date:10/20/2014)... 2014 Convey Computer , the ... from Iowa State University won first place in the ... Convey HC-2ex, the team’s solution achieved the highest overall ... the second place finisher. , Experts from all segments ... month long challenge, using a variety of design tools, ...
(Date:10/20/2014)... Oct. 20, 2014  GenVec, Inc. (NASDAQ: GNVC ... , Ph.D., from its board of directors effective on October ... 2003, and served as its chairman from June 2006 to ... Nominating and Corporate Governance and Audit Committees of the board.  ... a decade of dedicated service to GenVec, and its stockholders," ...
(Date:10/20/2014)... Local veterinary surgeon, Dr. Tim McCarthy is ... donor stem cells for dogs with osteoarthritis. Dr. McCarthy ... performed clinical stem cell therapy for 7 years. The ... a single injection of donor stem cells into one ... and inflammation in the treated joints. , Candidates ...
Breaking Biology Technology:Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3Zola P. Horovitz To Retire From GenVec Board 2Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... (NYSE: DGX ), the world,s leading provider ... for the fourth quarter ended December 31, 2011, adjusted ... per diluted share, compared to $179 million, or $1.03 ... of 2011, reported income from continuing operations was $190 ...
... Lieber, the Mark Hyman Jr. Professor of Chemistry, ... A pioneer in the synthesis of a wide ... unique physical properties of those materials, and the ... Lieber has demonstrated the use of nanoscale materials ...
...  A recent Van Andel Research Institute (VARI) study published in ... function of an essential plant hormone could profoundly change our ... to the development of new drugs for a variety of ... by the same team of investigators at VARI that was ...
Cached Biology Technology:Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 2Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 3Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 4Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 5Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 6Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 7Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 8Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 9Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 10Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 11Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 12Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 13Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 14Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 15Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 16Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 17Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 18Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 19Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 20Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 21Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 22Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 23Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 24Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 25Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 26Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 27Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 28Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process 2
(Date:10/16/2014)... constantly wages war on the human body. Battles ... stalemate. In pancreatic cancer, this stalemate—known as tumor ... aggressively malignant, a phenomena that is poorly understood. ... the laboratory of Salvatore Torquato, a Professor of ... conditions surrounding tumor dormancy and the switch to ...
(Date:10/16/2014)... tract infections and worldwide claims the lives of ... Ghent University have succeeded in developing a promising ... , Xavier Saelens (VIB/UGent): "We discovered a ... the development of a novel approach to vaccination ... numerous small children and elderly people." , ...
(Date:10/15/2014)... is a non-traditional biophysics textbook and it describes how ... journey of discovery into biological systems and provides an ... It is about how our genes make proteins that ... of cells in an organism. It quantifies the principles ... can be found on both large and small scales. ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2New perspectives for development of an RSV vaccine 2New book about life as seen from physics 2
... help scientists "build" new biological systems, Princeton University scientists ... enable the growth of living cells. The team ... nature, and the scientists showed that they can produce ... as proteins produced by nature,s own toolkit. ...
... ATHENS, Ohio (Jan. 6, 2011) Ohio University ... the bioengineering profession,s highest honor, the Fritz J. and ... Hood of Seattle, Washington, for his discoveries related to ... president and co-founder of the Institute for Systems Biology, ...
... at the University of Connecticut Health Center have identified a ... a predictor of heart attack. Their research, led by ... Cardiology Center, is published in the Jan. 11 issue of ... It found heart attack patients had elevated levels of the ...
Cached Biology News:Princeton scientists construct synthetic proteins that sustain life 2Princeton scientists construct synthetic proteins that sustain life 3DNA sequencing pioneer receives 2011 Russ Prize 2DNA sequencing pioneer receives 2011 Russ Prize 3
Biotin d anti-mouse Tim-1...
Mouse monoclonal [1-N-14] to Adenovirus Type 7 hexon C11 Immunogen: Purified Adenovirus type 7 Specificity: This antibody is specific for Adenovirus type 7 hexon C11....
Request Info...
... is the main excitatory neurotransmitter in the ... considered to act only on the ligand-gated ... that are involved in the fast excitatory ... to regulate enzymes producing second messengers via ...
Biology Products: